These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 18522775

  • 1. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
    Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, Yoshida H, Horinouchi M, Tabata K, Yonezawa S, Yoshimitsu M, Higuchi K, Nakao S, Anan R, Minagoe S, Tei C.
    J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
    [Abstract] [Full Text] [Related]

  • 2. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].
    Teraguchi H, Takenaka T, Yoshida A, Taguchi S, Ninomiya K, Yoshida H, Horinouchi M, Yonezawa S, Nakao S, Minagoe S, Tei S.
    J Cardiol; 2004 Feb; 43(2):98-9. PubMed ID: 15046052
    [Abstract] [Full Text] [Related]

  • 3. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.
    Weidemann F, Breunig F, Beer M, Sandstede J, Störk S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM.
    Eur Heart J; 2005 Jun; 26(12):1221-7. PubMed ID: 15728649
    [Abstract] [Full Text] [Related]

  • 4. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, Mehta AB.
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [Abstract] [Full Text] [Related]

  • 5. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F, Pieroni M, Chimenti C, Frustaci A, Sarais C, Cecchi F, Area Cardiologica-Advisory Board Plan Multidisciplinare "Diagnosi e Follow-up Malattia di Fabry".
    G Ital Cardiol (Rome); 2010 Feb; 11(7-8):566-72. PubMed ID: 21033333
    [Abstract] [Full Text] [Related]

  • 6. Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition.
    Barbey F, Brakch N, Linhart A, Rosenblatt-Velin N, Jeanrenaud X, Qanadli S, Steinmann B, Burnier M, Palecek T, Bultas J, Hayoz D.
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):839-44. PubMed ID: 16469946
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H.
    N Engl J Med; 1995 Aug 03; 333(5):288-93. PubMed ID: 7596372
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Electrocardiographic changes in early recognition of Fabry disease.
    Namdar M, Steffel J, Vidovic M, Brunckhorst CB, Holzmeister J, Lüscher TF, Jenni R, Duru F.
    Heart; 2011 Mar 03; 97(6):485-90. PubMed ID: 21270075
    [Abstract] [Full Text] [Related]

  • 16. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure.
    Aras D, Tufekcioglu O, Ergun K, Ozeke O, Yildiz A, Topaloglu S, Deveci B, Sahin O, Kisacik HL, Korkmaz S.
    J Card Fail; 2006 Dec 03; 12(9):726-33. PubMed ID: 17174235
    [Abstract] [Full Text] [Related]

  • 17. Fabry disease.
    Yuasa T, Takenaka T, Higuchi K, Uchiyama N, Horizoe Y, Cyaen H, Mizukami N, Takasaki K, Kisanuki A, Miyata M, Ohishi M.
    J Echocardiogr; 2017 Dec 03; 15(4):151-157. PubMed ID: 28674962
    [Abstract] [Full Text] [Related]

  • 18. Early detection of Fabry cardiomyopathy by tissue Doppler imaging.
    Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A.
    Circulation; 2003 Apr 22; 107(15):1978-84. PubMed ID: 12668521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fabry disease: cardiac manifestations and therapeutic options.
    Pierre-Louis B, Kumar A, Frishman WH.
    Cardiol Rev; 2009 Apr 22; 17(1):31-5. PubMed ID: 19092368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.